Literature DB >> 27698721

siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia.

Hao Cheng1, Zhifang Wu1, Xiaoyun He1, Qingzhen Liu1, Hongbin Jia1, Yan Di1, Qing Ji1.   

Abstract

Phosphodiesterase 4 (PDE4) has four subtypes: PDE4A, PDE4B, PDE4C and PDE4D. The expression of PDE4 subtypes in microglial cells and the specific contribution of each subtype to inflammation remain unclear. In this study, the expression of PDE4 subtypes in primary microglial cells was assayed. Primary microglial cells were then transfected with specific small interfering RNA (siRNA) against each PDE4 subtype. PDE4 subtype A-D knockdown was confirmed by quantitative polymerase chain reaction. Secreted cytokines in the supernatant and intracellular cyclic adenosine monophosphate (cAMP) levels of transfected cells were measured. The effect of PDE4B siRNA on the activation of extracellular regulated protein kinase (ERK) induced by lipopolysaccharide (LPS) in microglia was further tested by western blotting. Results showed that the primary microglial cells expressed all four types of PDE4s at the protein level. Transfection with the four siRNAs inhibited PDE4 subtype A-D mRNA expression, respectively. In primary microglial cells, treatment with PDE4B siRNA significantly inhibited the expression of tumor necrosis factor-α and interleukin (IL)-1β, and enhanced the expression of cAMP, while siRNAs to other subtypes had no significant effects. However, none of the four siRNAs had any significant effect on the expression of IL-10. Furthermore, in the PDE4B group, the level of phosphorylated ERK was reduced. Among the four PDE4 subtypes, PDE4B plays an important role in regulating inflammatory responses in microglia, potentially through initially regulating the intracellular cAMP concentration.

Entities:  

Keywords:  inflammation; microglia; phosphodiesterase 4B; small interfering RNA

Year:  2016        PMID: 27698721      PMCID: PMC5038198          DOI: 10.3892/etm.2016.3575

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  36 in total

Review 1.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 3.  Phosphodiesterase 4 and its inhibitors in inflammatory diseases.

Authors:  S-L Catherine Jin; Shiau-Li Ding; Shih-Chang Lin
Journal:  Chang Gung Med J       Date:  2012 May-Jun

4.  Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms.

Authors:  Jana Ninković; Sabita Roy
Journal:  Am J Pathol       Date:  2012-01-14       Impact factor: 4.307

Review 5.  PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.

Authors:  María Jesús Sanz; Julio Cortijo; Esteban J Morcillo
Journal:  Pharmacol Ther       Date:  2005-02-25       Impact factor: 12.310

6.  Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram.

Authors:  M Buttini; A Mir; K Appel; K H Wiederhold; S Limonta; P J Gebicke-Haerter; H W Boddeke
Journal:  Br J Pharmacol       Date:  1997-12       Impact factor: 8.739

7.  Induction of resting microglia in culture medium devoid of glycine and serine.

Authors:  J Tanaka; K Toku; S Matsuda; S Sudo; H Fujita; M Sakanaka; N Maeda
Journal:  Glia       Date:  1998-10       Impact factor: 7.452

8.  Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-kappaB pathway.

Authors:  Yang Xue; Ying Wang; De-chun Feng; Bao-guo Xiao; Ling-yun Xu
Journal:  Acta Pharmacol Sin       Date:  2008-02       Impact factor: 6.150

9.  The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.

Authors:  Suat Erdogan; Ozkan Aslantas; Sefa Celik; Esin Atik
Journal:  Res Vet Sci       Date:  2007-03-29       Impact factor: 2.534

Review 10.  cAMP signaling in leukocyte transendothelial migration.

Authors:  Magdalena J Lorenowicz; Mar Fernandez-Borja; Peter L Hordijk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-03-08       Impact factor: 8.311

View more
  2 in total

1.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

2.  Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4.

Authors:  Isabella Russo; Giulietta Di Benedetto; Alice Kaganovich; Jinhui Ding; Daniela Mercatelli; Michele Morari; Mark R Cookson; Luigi Bubacco; Elisa Greggio
Journal:  J Neuroinflammation       Date:  2018-10-27       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.